Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
76
NMR Quote, Financials, Valuation and Earnings
Last price:
$8.35
Seasonality move
:
6.14%
Day range:
$8.30 - $8.36
52-week range:
$4.86 - $8.50
Dividend yield:
4.95%
P/E ratio:
10.23x
P/S ratio:
0.83x
P/B ratio:
1.03x
Volume:
613.6K
Avg. volume:
1M
1-year change:
43.45%
Market cap:
$24.4B
Revenue:
$31.1B
EPS (TTM):
$0.81
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $15.2B | $14.2B | $18.3B | $28.7B | $31.1B | |
| Revenue Growth (YoY) | -15.29% | -6.8% | 29.15% | 56.92% | 8.08% | |
| Cost of Revenues | $3.7B | $3.5B | $9.8B | $19.3B | $20.2B | |
| Gross Profit | $11.5B | $10.7B | $8.5B | $9.4B | $10.8B | |
| Gross Profit Margin | 75.79% | 75.23% | 46.36% | 32.79% | 34.91% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$172.6M | $1B | $273.8M | $155.6M | $54.4M | |
| Operating Expenses | $9.4B | $8.7B | $7.4B | $7.5B | $7.7B | |
| Operating Income | $2.1B | $2B | $1.1B | $1.9B | $3.1B | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $2.2B | $2B | $1.1B | $1.9B | $3.1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $662.6M | $712.7M | $426.5M | $668.2M | $818M | |
| Net Income to Company | $1.5B | $1.3B | $676.5M | $1.2B | $2.3B | |
| Minority Interest in Earnings | $68.7M | $31.5M | -$8.2M | $78.5M | $42.8M | |
| Net Income to Common Excl Extra Items | $1.5B | $1.3B | $676.5M | $1.2B | $2.3B | |
| Basic EPS (Cont. Ops) | $0.47 | $0.42 | $0.23 | $0.38 | $0.76 | |
| Diluted EPS (Cont. Ops) | $0.46 | $0.40 | $0.22 | $0.36 | $0.73 | |
| Weighted Average Basic Share | $3.1B | $3.1B | $3B | $3B | $3B | |
| Weighted Average Diluted Share | $3.1B | $3.2B | $3.1B | $3.1B | $3.1B | |
| EBITDA | $2.7B | $2.5B | $1.5B | $2.3B | $3.5B | |
| EBIT | $2.1B | $2B | $1.1B | $1.9B | $3.1B | |
| Revenue (Reported) | $15.2B | $14.2B | $18.3B | $28.7B | $31.1B | |
| Operating Income (Reported) | $2.1B | $2B | $1.1B | $1.9B | $3.1B | |
| Operating Income (Adjusted) | $2.1B | $2B | $1.1B | $1.9B | $3.1B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $3.4B | $3.9B | $7B | $8.3B | $7.9B | |
| Revenue Growth (YoY) | -12.81% | 12.03% | 81.52% | 18.76% | -5.35% | |
| Cost of Revenues | $932.6M | $1.9B | $4.8B | $5.5B | $4.8B | |
| Gross Profit | $2.5B | $2B | $2.2B | $2.8B | $3.1B | |
| Gross Profit Margin | 72.93% | 51.41% | 31.44% | 34.05% | 38.95% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $23.2M | $30.5M | $27.1M | -$6.4M | -- | |
| Operating Expenses | $2.3B | $1.8B | $1.8B | $1.9B | $2.1B | |
| Operating Income | $167.8M | $227.6M | $392.5M | $891.3M | $926.6M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $167.8M | $227.6M | $392.5M | $891.3M | $926.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $117.9M | $106.6M | $146.3M | $236.6M | $277M | |
| Net Income to Company | $48.1M | $124.5M | $245.1M | -- | -- | |
| Minority Interest in Earnings | $20.6M | -$202.4K | $2.4M | -$4.6M | $25.2M | |
| Net Income to Common Excl Extra Items | $49.8M | $121M | $246.2M | $654.7M | $649.6M | |
| Basic EPS (Cont. Ops) | $0.01 | $0.04 | $0.08 | $0.22 | $0.21 | |
| Diluted EPS (Cont. Ops) | $0.01 | $0.04 | $0.08 | $0.22 | $0.21 | |
| Weighted Average Basic Share | $3.1B | $3B | $3B | $3B | $2.9B | |
| Weighted Average Diluted Share | $3.2B | $3.1B | $3.1B | $3B | $3B | |
| EBITDA | $303.4M | $338.2M | $496.5M | $993.4M | $1B | |
| EBIT | $167.8M | $227.6M | $392.5M | $891.3M | $926.6M | |
| Revenue (Reported) | $3.4B | $3.9B | $7B | $8.3B | $7.9B | |
| Operating Income (Reported) | $167.8M | $227.6M | $392.5M | $891.3M | $926.6M | |
| Operating Income (Adjusted) | $167.8M | $227.6M | $392.5M | $891.3M | $926.6M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $13.7B | $14.1B | $24.8B | $31.3B | $30.8B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $3.7B | $4.8B | $15.8B | $21B | $19.1B | |
| Gross Profit | $10B | $9.3B | $9B | $10.4B | $11.8B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $467.7M | $18.6M | $195.8M | $62.8M | -- | |
| Operating Expenses | $9.4B | $7.8B | $7.5B | $7.7B | $8.2B | |
| Operating Income | $577.1M | $1.4B | $1.5B | $2.7B | $3.6B | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $577.1M | $1.4B | $1.5B | $2.7B | $3.6B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $553.5M | $529.1M | $525.9M | $810.2M | $1B | |
| Net Income to Company | $37.4M | $931M | $985.3M | -- | -- | |
| Minority Interest in Earnings | $74.4M | -$12M | $23.1M | $68.4M | $76.2M | |
| Net Income to Common Excl Extra Items | $23.5M | $919M | $965.6M | $1.9B | $2.6B | |
| Basic EPS (Cont. Ops) | -$0.01 | $0.31 | $0.31 | $0.61 | $0.84 | |
| Diluted EPS (Cont. Ops) | -$0.03 | $0.30 | $0.30 | $0.59 | $0.81 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $1.2B | $1.9B | $1.9B | $3.1B | $4B | |
| EBIT | $577.1M | $1.4B | $1.5B | $2.7B | $3.6B | |
| Revenue (Reported) | $13.7B | $14.1B | $24.8B | $31.3B | $30.8B | |
| Operating Income (Reported) | $577.1M | $1.4B | $1.5B | $2.7B | $3.6B | |
| Operating Income (Adjusted) | $577.1M | $1.4B | $1.5B | $2.7B | $3.6B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $7.1B | $7B | $13.5B | $16.1B | $15.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.8B | $3.1B | $9.1B | $10.8B | $9.6B | |
| Gross Profit | $5.4B | $4B | $4.4B | $5.4B | $6.3B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $292.3M | -$17.9M | $112.1M | $23M | $41.2M | |
| Operating Expenses | $4.5B | $3.6B | $3.7B | $3.8B | $4.2B | |
| Operating Income | $885.6M | $318M | $729.2M | $1.6B | $2B | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $885.6M | $318M | $729.2M | $1.6B | $2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $378.8M | $193.9M | $294.8M | $438.7M | $642.5M | |
| Net Income to Company | $505.1M | $127.5M | $433.2M | -- | -- | |
| Minority Interest in Earnings | $34.4M | -$10.2M | $21M | $11.4M | $45.3M | |
| Net Income to Common Excl Extra Items | $506.8M | $124.1M | $434.3M | $1.1B | $1.4B | |
| Basic EPS (Cont. Ops) | $0.16 | $0.04 | $0.14 | $0.37 | $0.46 | |
| Diluted EPS (Cont. Ops) | $0.15 | $0.04 | $0.13 | $0.36 | $0.44 | |
| Weighted Average Basic Share | $6.1B | $6B | $6.1B | $5.9B | $5.9B | |
| Weighted Average Diluted Share | $6.3B | $6.2B | $6.3B | $3B | $6.1B | |
| EBITDA | $1.2B | $544.5M | $942.2M | $1.8B | $2.3B | |
| EBIT | $885.6M | $318M | $729.2M | $1.6B | $2B | |
| Revenue (Reported) | $7.1B | $7B | $13.5B | $16.1B | $15.9B | |
| Operating Income (Reported) | $885.6M | $318M | $729.2M | $1.6B | $2B | |
| Operating Income (Adjusted) | $885.6M | $318M | $729.2M | $1.6B | $2B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $34.3B | $30B | $31.8B | $31.6B | $33.9B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $4.2B | $3.4B | $2.9B | $3B | $2.7B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $169.9M | $140.6M | $148.1M | $150.7M | $187.1M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $314.5B | $298B | $308.6B | $311.5B | $329.9B | |
| Property Plant And Equipment | $4.2B | $3.5B | $3.5B | $3B | $2.9B | |
| Long-Term Investments | $290.3B | $267.5B | $270.7B | $270.9B | $277.8B | |
| Goodwill | $119.2M | $118M | $132.4M | $127.3M | $114.9M | |
| Other Intangibles | $144.1M | $127.8M | $139.3M | $126.4M | $375.2M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $384.8B | $357.7B | $358.9B | $364.4B | $379.8B | |
| Accounts Payable | $13.2B | $12.5B | $10.2B | $8.7B | $9.2B | |
| Accrued Expenses | $3.9B | $3.7B | $3.6B | $3.9B | $3.7B | |
| Current Portion Of Long-Term Debt | $8.2B | $7.5B | $5.3B | $5.5B | $6.7B | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $268.5B | $237.7B | $236.3B | $242B | $249.5B | |
| Long-Term Debt | $80.1B | $87B | $89.5B | $90.3B | $102.1B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $359.8B | $333.2B | $334.7B | $341.6B | $355.9B | |
| Common Stock | $5.4B | $4.9B | $4.5B | $3.9B | $4B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $24.4B | $24B | $23.7B | $22.1B | $23.2B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $556.7M | $479.5M | $567.8M | $649.7M | $736.4M | |
| Total Equity | $24.9B | $24.5B | $24.2B | $22.8B | $23.9B | |
| Total Liabilities and Equity | $384.8B | $357.7B | $358.9B | $364.4B | $379.8B | |
| Cash and Short Terms | $34.3B | $30B | $31.8B | $31.6B | $33.9B | |
| Total Debt | $84.3B | $90.8B | $94.2B | $97.8B | $111.4B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $37.5B | $27.8B | $30.6B | $37.7B | $43.6B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $4.3B | $3.7B | $2.3B | $2.9B | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $172.6M | $154.3M | $194.2M | $190M | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $326.5B | $305.9B | $318.2B | $348.6B | $358.2B | |
| Property Plant And Equipment | $4.1B | $3B | $3.1B | $3.1B | $3B | |
| Long-Term Investments | $292.4B | $271.5B | $279.7B | $298.4B | $291.4B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $388.5B | $356B | $367.3B | $401.7B | $408.8B | |
| Accounts Payable | $13.1B | $11.5B | $8.9B | $9B | -- | |
| Accrued Expenses | $3.5B | $2.9B | $3.2B | $3.3B | -- | |
| Current Portion Of Long-Term Debt | $10.6B | $8.8B | $7.1B | $6.3B | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $260.7B | $241B | $246.1B | $257.6B | $259B | |
| Long-Term Debt | $97.6B | $87.5B | $76.7B | $111.1B | $120.9B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $363.4B | $333.7B | $344.7B | $378B | $384.3B | |
| Common Stock | $5.3B | $4.1B | $4B | $4.2B | $4B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $605.4M | $444.4M | $541.5M | $668.5M | $835.4M | |
| Total Equity | $25.1B | $22.3B | $22.6B | $23.7B | $24.4B | |
| Total Liabilities and Equity | $388.5B | $356B | $367.3B | $401.7B | $408.8B | |
| Cash and Short Terms | $37.5B | $27.8B | $30.6B | $37.7B | $43.6B | |
| Total Debt | $97.6B | $87.5B | $76.7B | $111.1B | $120.9B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.5B | $1.3B | $676.5M | $1.2B | $2.3B | |
| Depreciation & Amoritzation | $602M | $529.7M | $453.3M | $424.2M | $404.4M | |
| Stock-Based Compensation | $266.4M | $248.6M | $259.9M | $246M | $253.1M | |
| Change in Accounts Receivable | $8.8B | $991.9M | $1.3B | -$1.9B | -$1.2B | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $18.1B | $12.2B | -$3.1B | $1B | -$14.2B | |
| Capital Expenditures | $1.1B | $990.7M | $1.3B | $1B | $1.2B | |
| Cash Acquisitions | $105.2M | -- | -- | $3.2M | -- | |
| Cash From Investing | -$11B | -$24.7B | -$3.6B | -$3.7B | $2.1B | |
| Dividends Paid (Ex Special Dividend) | $720M | $629.3M | $422.5M | $416.1M | $738.2M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $47.1B | $50.6B | $36.2B | $35.3B | $41.5B | |
| Long-Term Debt Repaid | -$52.9B | -$42.9B | -$28.6B | -$28.1B | -$34.2B | |
| Repurchase of Common Stock | $103.7K | $352.8M | $182.5M | $422M | $387.1M | |
| Other Financing Activities | -$134M | -$100.5M | $96.5M | -$30.2M | -$240.5M | |
| Cash From Financing | -$18.3B | $9.5B | $8.6B | $4.3B | $14B | |
| Beginning Cash (CF) | $31.8B | $27.3B | $28.7B | $28B | $29.6B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$10.6B | -$1.6B | $3B | $3.2B | $1.8B | |
| Ending Cash (CF) | $21.7B | $27.1B | $32.8B | $32.7B | $31.2B | |
| Levered Free Cash Flow | $17B | $11.3B | -$4.4B | $25.2M | -$15.5B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $48.1M | $124.5M | $245.1M | -- | -- | |
| Depreciation & Amoritzation | $135.4M | $109.9M | $102.6M | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $38.7M | -$52.1M | -$2.4B | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$2.7B | $6.5B | -$662.9M | -- | -- | |
| Capital Expenditures | $116.2M | $236M | $214.9M | -- | -- | |
| Cash Acquisitions | -- | -- | -$19.3K | -- | -- | |
| Cash From Investing | $5.5B | -$7.6B | -$2.1B | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -$1.7M | -$11.1M | -$8M | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $14.6B | $4.7B | $13.8B | -- | -- | |
| Long-Term Debt Repaid | -$9.4B | -$2.2B | -$11.6B | -- | -- | |
| Repurchase of Common Stock | $27.2K | -$6.1M | $141M | -- | -- | |
| Other Financing Activities | -- | $25.7M | -$67.5M | -- | -- | |
| Cash From Financing | $2.6B | $2.3B | $3.2B | -- | -- | |
| Beginning Cash (CF) | $34.4B | $25.4B | $27.5B | $33.7B | $39.7B | |
| Foreign Exchange Rate Adjustment | $121.6M | $555.6M | $392.9M | -- | -- | |
| Additions / Reductions | $5.5B | $1.8B | $814.8M | -- | -- | |
| Ending Cash (CF) | $40B | $27.8B | $28.7B | -- | -- | |
| Levered Free Cash Flow | -$2.9B | $6.3B | -$877.8M | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.6B | -$373.1M | $854.4M | $859.8M | -- | |
| Depreciation & Amoritzation | $580.9M | $579.2M | $463M | $431.6M | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $748.8M | -$4B | -$2.2B | -$76.3M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $7.8B | $6.1B | $7.9B | -$15.8B | -- | |
| Capital Expenditures | $939.5M | $1.1B | $1.4B | $1B | $198M | |
| Cash Acquisitions | $127.7M | $1.1M | -- | $3.1M | -$139.6K | |
| Cash From Investing | -$6.2B | -$15.2B | -$17.1B | $13.6B | -- | |
| Dividends Paid (Ex Special Dividend) | $715.4M | $644.7M | $408.6M | $423.9M | -$9.5M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $24B | $57B | $35.2B | $39.4B | -- | |
| Long-Term Debt Repaid | -$23.3B | -$55.8B | -$30B | -$31.3B | -- | |
| Repurchase of Common Stock | $286.6M | $357.4M | $175.7M | $142M | -- | |
| Other Financing Activities | -- | -- | -- | $89.8M | -- | |
| Cash From Financing | $1.5B | $7.3B | $8.7B | $7.3B | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.6B | -$398.3M | $1.4B | $5.8B | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $6.9B | $5.1B | $6.5B | -$16.8B | -- | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $505.1M | $127.5M | $433.2M | -- | -- | |
| Depreciation & Amoritzation | $269.2M | $225.8M | $211.6M | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$1.1B | -$2B | -$2.7B | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2.4B | $5B | -$5.1B | -- | -- | |
| Capital Expenditures | $472M | $416.4M | $372.2M | -- | -- | |
| Cash Acquisitions | -- | -- | $3.1M | -- | -- | |
| Cash From Investing | -$3.8B | -$9.4B | $4.1B | -- | -- | |
| Dividends Paid (Ex Special Dividend) | $418.3M | $314.4M | $254.1M | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $21.1B | $7.2B | $17.1B | -- | -- | |
| Long-Term Debt Repaid | -$15B | -$3.8B | -$14.2B | -- | -- | |
| Repurchase of Common Stock | $54.6K | $172.7M | $141M | -- | -- | |
| Other Financing Activities | -- | $6.5M | -$35M | -- | -- | |
| Cash From Financing | $4.9B | $5.1B | $1.6B | -- | -- | |
| Beginning Cash (CF) | $63.5B | $51B | $55.5B | $57.7B | $74.2B | |
| Foreign Exchange Rate Adjustment | $61.2M | $2B | $1.4B | -- | -- | |
| Additions / Reductions | $3.5B | $2.7B | $2.1B | -- | -- | |
| Ending Cash (CF) | $67.1B | $55.7B | $59B | -- | -- | |
| Levered Free Cash Flow | $1.9B | $4.6B | -$5.5B | -- | -- | |
Get NMR Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
NMR
Sector
P/E ratio
10.23x
12.24x
PEG ratio
0.27x
0.31x
P/B ratio
1.03x
1.11x
Price / LTM sales
0.83x
1.85x
Growth Metrics
NMR
Sector
Revenue growth
-5.35%
5.54%
Earnings growth
-4.35%
14.87%
Revenue (5-year growth)
11.58%
8.85%
Earnings forecast
--
$0.62
Profitability
NMR
Sector
Profitability FY 2024
$10.8B
--
Return on invested capital
1.01%
5.03%
Return on assets
0.65%
1.01%
Return on equity
10.64%
9.68%
Earnings Date
Last Earnings Date
Oct
28
Next Earnings Date
Jan
30
Estimated Next Earnings Date
Jan
27
Balance Sheet
NMR
Sector
Total cash
$43.6B
$431.4M
Short term investments
--
$211.3M
Total assets
$379.8B
$3.1B
Long term debt
$120.9B
$79.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 26
Travere Therapeutics, Inc. [TVTX] is down 2.06% over the past day.
Buy
64
ZCSH alert for Dec 26
Grayscale Zcash Trust (ZEC) [ZCSH] is down 0.65% over the past day.
Buy
66
ASTS alert for Dec 26
AST Spacemobile, Inc. [ASTS] is down 5.94% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
